Yan-yan Xue

88 Jiefang Road
Hangzhou, 310009, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Correction: CD2AP deficiency aggravates Alzheimer's disease phenotypes and pathology through p38 MAPK activation.

Correction: CD2AP deficiency aggravates Alzheimer's disease phenotypes and pathology through p38 MAPK activation.

Journal: Translational neurodegeneration
Published: January 17, 2025

CD2AP deficiency aggravates Alzheimer's disease phenotypes and pathology through p38 MAPK activation.

CD2AP deficiency aggravates Alzheimer's disease phenotypes and pathology through p38 MAPK activation.

Journal: Translational neurodegeneration
Published: June 03, 2024

Hybrid Membrane-Coated Nanoparticles for Precise Targeting and Synergistic Therapy in Alzheimer's Disease.

Hybrid Membrane-Coated Nanoparticles for Precise Targeting and Synergistic Therapy in Alzheimer's Disease.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 14, 2023

Alzheimer's disease early diagnostic and staging biomarkers revealed by large-scale cerebrospinal fluid and serum proteomic profiling.

Alzheimer's disease early diagnostic and staging biomarkers revealed by large-scale cerebrospinal fluid and serum proteomic profiling.

Journal: Innovation (Cambridge (Mass.))
Published: June 12, 2023

Identification and functional characterization of novel variants of MAPT and GRN in Chinese patients with frontotemporal dementia.

Identification and functional characterization of novel variants of MAPT and GRN in Chinese patients with frontotemporal dementia.

Journal: Neurobiology of aging
Published: March 15, 2022

Clinical Characterization and Founder Effect Analysis in Chinese Patients with Phospholipase A2-Associated Neurodegeneration.

Clinical Characterization and Founder Effect Analysis in Chinese Patients with Phospholipase A2-Associated Neurodegeneration.

Journal: Brain sciences
Published: March 08, 2022

Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer's Disease Continuum.

Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer's Disease Continuum.

Journal: Frontiers in aging neuroscience
Published: January 04, 2022

Alzheimer's disease susceptibility locus in CD2AP is associated with increased cerebrospinal fluid tau levels in mild cognitive impairment.

Alzheimer's disease susceptibility locus in CD2AP is associated with increased cerebrospinal fluid tau levels in mild cognitive impairment.

Journal: Neuroscience letters
Published: October 21, 2021

Identification of a large homozygous SPG21 deletion in a Chinese patient with Mast syndrome.

Identification of a large homozygous SPG21 deletion in a Chinese patient with Mast syndrome.

Journal: CNS neuroscience & therapeutics
Published: July 13, 2021

Optimal Combinations of AT(N) Biomarkers to Determine Longitudinal Cognition in the Alzheimer's Disease.

Optimal Combinations of AT(N) Biomarkers to Determine Longitudinal Cognition in the Alzheimer's Disease.

Journal: Frontiers in aging neuroscience
Published: June 01, 2021

A de novo variant of POLR3B causes demyelinating Charcot-Marie-Tooth disease in a Chinese patient: a case report.

A de novo variant of POLR3B causes demyelinating Charcot-Marie-Tooth disease in a Chinese patient: a case report.

Journal: BMC neurology
Published: May 22, 2021

Identification of pathogenic C9orf72 hexanucleotide repeat expansion in a Chinese patient with frontotemporal dementia: A case report.

Identification of pathogenic C9orf72 hexanucleotide repeat expansion in a Chinese patient with frontotemporal dementia: A case report.

Journal: CNS neuroscience & therapeutics
Published: February 03, 2021
Showing 1-12 of 15

Last Updated: 09/26/2026